*






4050%
25%
---


1.

2.




3.



1

2


:25 1
60 20 20
:
45
:25 1
65 25 40
:
:25

50
:



osteoporosis OP



I II



PTH


1.




2.
3.
4.

1.
BGP
HOLG

2.X


3.
WHO1994 SPA
X DEXA CT
2.5SD


1
2

1
2


1.

D
2.





1.
D

800 1000mg
D 400IU
D
A
C

 )
1.

2.

3.







1.
1~10
.

3. D

D



200 300ml



4.


1.

2.

3.
4.

5.

2

degenerative
osteoarthritis





1.





2.




1.
2.
3.
4.
5.

1.X



2.CT
X
3.MRI




1.
2.

3.


1.
2.
3.
4.
5.









1 2


hypertension
60

SBP 140mmHg 18.7kPa
DBP 90mmHg 12.0kPa
140/90mmHg




1.
2.


3.




1.



2.




1.
2.


1. 130mmHg
2.
3.
4.

5.


(
)













(
)



20mmHg


1.

24

2.


1.

6g









ACEI












140 90mmHg
70mmHg;
150mmHg

135 85mmHg




1.

20 30g
15 20g
2.

3.


1.




24
2.
3.



coronary heart
disease



70


1.
2.

3.
A












 51 6 3




ST T



1.
2.

3.

4.


5.

1.
2.
1
2 0.3 0.6mg
10mg

3


1.
2.
3.

4.

5.

1.

2.






 80 10

1 6 12
2
3

4

 ,

,
.


1.
2.
3

4. 85
5.




1.
Q Q
ST

T
Q
2.

CK AST
LDH CK AST
CK










24 48










,

1
5 10

2 5 100 250ml

3 5 100 200ml
4





 /




1
2
3
4
5
6
7
8
1
2
3
4

5
9
1ST
2T
3QRS Q







30
/min 140/min
90mmHg 12.00kPa
60mmHg 8.00kPa


/







1825

COPD




56 6
3
5



X


COPD

1.

2.





1.
2.






1.
2.X
3.
(FEV1 FVC 60%
80
40
4. PaO2 PaCO2





1. 1 2L min
2.
1.5 2.5L min,
15



 /

1.

2.

3.
4.

5.

1.
2.

3.

4.